Atherosclerosis

Atherosclerosis
source
Name	Atherosclerosis
Diseasesdb	1039
Icd10	I, 70
Icd9	440

Atherosclerosis is a condition characterized by the buildup of plaque in the arteries, leading to their hardening and narrowing, as described by Rudolf Virchow and Carl von Rokitansky. This process is influenced by various factors, including inflammation, lipid metabolism, and endothelial dysfunction, as studied by Salvador Moncada and Louis Ignarro. The condition is a major contributor to cardiovascular disease, which is a leading cause of death worldwide, according to the World Health Organization and American Heart Association. Atherosclerosis is often associated with other conditions, such as hypertension, diabetes mellitus, and hyperlipidemia, as noted by Paul Dudley White and Helen B. Taussig.

Definition_and_Pathophysiology

Atherosclerosis is defined as a chronic inflammatory disease characterized by the accumulation of lipids, macrophages, and smooth muscle cells in the arterial wall, as described by Russell Ross and John Glomset. The pathophysiology of atherosclerosis involves the formation of foam cells, which are macrophages that have ingested low-density lipoprotein (LDL) particles, as studied by Joseph Goldstein and Michael Brown. The condition is also influenced by oxidative stress, endothelial dysfunction, and inflammation, as noted by Peter Libby and Gerald Shulman. The National Institutes of Health and European Society of Cardiology have conducted extensive research on the definition and pathophysiology of atherosclerosis, with contributions from Michael Davies and Andrew Henderson.

Risk_Factors

The risk factors for atherosclerosis include hypertension, diabetes mellitus, hyperlipidemia, and smoking, as identified by Framingham Heart Study and Nurses' Health Study. Other risk factors include obesity, physical inactivity, and family history of cardiovascular disease, as noted by American College of Cardiology and American Heart Association. The Interheart Study and Prospective Urban Rural Epidemiology (PURE) study have also investigated the risk factors for atherosclerosis, with contributions from Salim Yusuf and Koon Teo. Additionally, air pollution and psychosocial stress have been identified as potential risk factors for atherosclerosis, as studied by New York University and Harvard School of Public Health.

Clinical_Presentation

The clinical presentation of atherosclerosis can vary depending on the location and severity of the disease, as described by William Osler and William Harvey. Patients with atherosclerosis may experience angina pectoris, myocardial infarction, or stroke, as noted by Paul Wood and John Cairns. The condition can also cause peripheral artery disease, renal artery stenosis, and mesenteric ischemia, as studied by University of California, Los Angeles and University of Oxford. The European Society of Cardiology and American College of Cardiology have developed guidelines for the clinical presentation and diagnosis of atherosclerosis, with contributions from Eric Topol and Valentin Fuster.

Diagnosis

The diagnosis of atherosclerosis involves a combination of medical history, physical examination, and imaging tests, as described by University of Pennsylvania and Massachusetts General Hospital. Imaging tests such as coronary angiography, computed tomography angiography (CTA), and magnetic resonance angiography (MRA) can be used to visualize the arteries and detect plaque buildup, as noted by National Institutes of Health and European Society of Cardiology. The American Heart Association and American College of Cardiology have developed guidelines for the diagnosis and treatment of atherosclerosis, with contributions from Sidney Smith and Robert Califf. Additionally, biomarkers such as C-reactive protein and lipoprotein(a), as studied by Harvard University and University of California, San Francisco, can be used to assess the risk of atherosclerosis.

Treatment_and_Management

The treatment and management of atherosclerosis involve a combination of lifestyle modifications and pharmacological interventions, as described by American Heart Association and European Society of Cardiology. Lifestyle modifications include dietary changes, exercise, and smoking cessation, as noted by National Institutes of Health and World Health Organization. Pharmacological interventions include statins, beta blockers, and antiplatelet agents, as studied by University of Oxford and University of California, Los Angeles. The European Society of Cardiology and American College of Cardiology have developed guidelines for the treatment and management of atherosclerosis, with contributions from Eric Topol and Valentin Fuster. Additionally, revascularization procedures such as percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) may be necessary in some cases, as noted by Columbia University and University of Pennsylvania.

Epidemiology

The epidemiology of atherosclerosis is a major public health concern, with the condition affecting millions of people worldwide, as noted by World Health Organization and Centers for Disease Control and Prevention. The Global Burden of Disease Study and Framingham Heart Study have investigated the epidemiology of atherosclerosis, with contributions from Christopher Murray and Daniel Levy. The condition is more common in developed countries and is influenced by factors such as age, sex, and socioeconomic status, as studied by Harvard University and University of California, Berkeley. The American Heart Association and European Society of Cardiology have developed strategies for the prevention and treatment of atherosclerosis, with contributions from Sidney Smith and Robert Califf. Additionally, health disparities and access to healthcare can affect the epidemiology of atherosclerosis, as noted by National Institutes of Health and World Health Organization. Category:Diseases